All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Recipharm AB (publ) revenue reports

Recipharm AB (publ) financial reports, Recipharm AB (publ) annual revenue in 2024. When does Recipharm AB (publ) report revenue?
Add to widgets
Added to widgets

Recipharm AB (publ) total revenue, net income and dynamics of changes in Swedish krona today

The dynamics of net revenue of Recipharm AB (publ) rose. The change amounted to 137 900 000 kr. The dynamics of net revenue is shown in comparison with the previous report. The dynamics of Recipharm AB (publ) net income rose by 8 600 000 kr. The assessment of the dynamics of Recipharm AB (publ) net income was made in comparison with the previous report. These are the main financial indicators of Recipharm AB (publ). Recipharm AB (publ) financial report on the graph shows the dynamics of assets. Information on Recipharm AB (publ) net income on the chart on this page is drawn in blue bars. Recipharm AB (publ) total revenue on the graph is shown in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019 1 981 200 000 kr - 89 400 000 kr -
30/09/2019 1 843 300 000 kr - 80 800 000 kr -
30/06/2019 1 892 400 000 kr - 93 700 000 kr -
31/03/2019 1 862 100 000 kr - 79 200 000 kr -
Show:
to

Recipharm AB (publ) financial report charts

The dates of the latest financial statements of Recipharm AB (publ): 31/03/2019, 30/09/2019, 31/12/2019. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Recipharm AB (publ) for today is 31/12/2019. Gross profit Recipharm AB (publ) is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Recipharm AB (publ) is 1 403 600 000 kr

Recipharm AB (publ) quarterly report dates

Cost of revenue Recipharm AB (publ) is the total cost of producing and distributing of products and services of a company. Cost of revenue Recipharm AB (publ) is 577 600 000 kr Total revenue Recipharm AB (publ) refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Recipharm AB (publ) is 1 981 200 000 kr Operating revenue Recipharm AB (publ) is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Recipharm AB (publ) is 1 981 200 000 kr

Operating income Recipharm AB (publ) is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Recipharm AB (publ) is 19 400 000 kr Net income Recipharm AB (publ) is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Recipharm AB (publ) is 89 400 000 kr Current assets Recipharm AB (publ) is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Recipharm AB (publ) is 4 224 000 000 kr

  31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 403 600 000 kr 1 282 400 000 kr 1 384 500 000 kr 1 336 300 000 kr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
577 600 000 kr 560 900 000 kr 507 900 000 kr 525 800 000 kr
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 981 200 000 kr 1 843 300 000 kr 1 892 400 000 kr 1 862 100 000 kr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
1 981 200 000 kr 1 843 300 000 kr 1 892 400 000 kr 1 862 100 000 kr
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
19 400 000 kr 92 700 000 kr 150 100 000 kr 109 100 000 kr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
89 400 000 kr 80 800 000 kr 93 700 000 kr 79 200 000 kr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - -
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
1 961 800 000 kr 1 750 600 000 kr 1 742 300 000 kr 1 753 000 000 kr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
4 224 000 000 kr 3 955 400 000 kr 4 004 000 000 kr 3 872 200 000 kr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
13 761 900 000 kr 13 559 400 000 kr 13 496 300 000 kr 13 374 500 000 kr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 054 900 000 kr 873 400 000 kr 806 000 000 kr 816 800 000 kr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
1 564 100 000 kr 1 583 200 000 kr 1 685 800 000 kr 1 611 500 000 kr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
8 071 500 000 kr 7 756 500 000 kr 7 870 600 000 kr 7 794 100 000 kr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
58.65 % 57.20 % 58.32 % 58.28 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
5 690 800 000 kr 5 802 700 000 kr 5 625 400 000 kr 5 580 500 000 kr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
107 700 000 kr 223 800 000 kr 258 600 000 kr 217 900 000 kr

Last revenue report of Recipharm AB (publ) was 31/12/2019. According to last financial report total revenue in Recipharm AB (publ) was 1 981 200 000 Swedish krona and changed by 0% since last year. Net income in Recipharm AB (publ) was 89 400 000 kr in last quartal, net income changes to 0%.

Total assets Recipharm AB (publ) refers to the total amount of assets owned by a person or entity. Total assets Recipharm AB (publ) is 13 761 900 000 kr Current cash Recipharm AB (publ) - the sum of all of the cash a company has on the date of report. Current cash Recipharm AB (publ) is 1 054 900 000 kr Current debt Recipharm AB (publ) is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Recipharm AB (publ) is 1 564 100 000 kr

Recipharm AB (publ) stocks data

Recipharm AB (publ) financials